| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 798.90B | 764.81B | 736.56B | 692.16B | 611.63B | 550.34B |
| Gross Profit | 293.78B | 275.30B | 261.01B | 239.83B | 216.07B | 185.80B |
| EBITDA | 202.70B | 182.74B | 167.09B | 154.67B | 144.60B | 123.82B |
| Net Income | 105.17B | 93.76B | 79.64B | 76.31B | 71.44B | 52.87B |
Balance Sheet | ||||||
| Total Assets | 948.54B | 928.50B | 922.77B | 838.22B | 789.65B | 656.54B |
| Cash, Cash Equivalents and Short-Term Investments | 108.66B | 168.60B | 173.94B | 129.26B | 115.61B | 153.19B |
| Total Debt | 236.16B | 271.02B | 298.54B | 237.74B | 250.42B | 165.59B |
| Total Liabilities | 442.97B | 490.54B | 519.75B | 435.81B | 447.17B | 323.33B |
| Stockholders Equity | 501.66B | 434.04B | 399.53B | 399.01B | 339.36B | 330.50B |
Cash Flow | ||||||
| Free Cash Flow | 137.90B | 123.54B | 134.79B | 106.84B | 91.31B | 76.96B |
| Operating Cash Flow | 143.42B | 130.20B | 142.28B | 118.90B | 98.14B | 84.59B |
| Investing Cash Flow | -92.50B | -47.59B | -53.98B | -61.19B | -130.55B | -31.85B |
| Financing Cash Flow | -87.45B | -87.31B | -47.02B | -44.92B | -8.00B | -1.86B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥72.83B | 7.46 | ― | 3.28% | 5.28% | 28.90% | |
70 Outperform | ¥755.88B | 20.55 | ― | 1.39% | 4.95% | 9.54% | |
68 Neutral | ¥2.44T | 29.12 | 22.48% | 1.14% | 4.50% | 16.63% | |
67 Neutral | ¥422.50B | 18.98 | ― | 2.17% | 10.42% | 28.75% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
57 Neutral | ¥673.97B | 22.20 | 10.07% | 1.76% | 11.66% | -0.21% |
Nomura Research Institute reported solid growth for the nine months ended December 31, 2025, with revenue rising 6.0% year on year to ¥602.3 billion and operating profit climbing 16.0% to ¥118.8 billion, reflecting improved profitability. Profit attributable to owners of the parent increased 15.9% to ¥83.2 billion, while basic earnings per share reached ¥145.21, supported by a stronger balance sheet as equity attributable to owners of the parent rose to ¥501.7 billion and the equity ratio improved to 52.9%. The company maintained its previously announced guidance for the full fiscal year ending March 31, 2026, projecting revenue of ¥810.0 billion and profit attributable to owners of the parent of ¥104.0 billion, and also affirmed its dividend outlook, targeting a higher annual dividend of ¥74.00 per share compared with ¥63.00 in the prior fiscal year, signaling confidence in earnings growth and shareholder returns.
The most recent analyst rating on (JP:4307) stock is a Buy with a Yen7000.00 price target. To see the full list of analyst forecasts on Nomura Research Institute stock, see the JP:4307 Stock Forecast page.